UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Amendment No. 1)
☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended March 31, 2021
or
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _______________________ to ___________________________
Commission file number 001-38021
HAMILTON LANE INCORPORATED
(Exact name of Registrant as specified in its charter)
Delaware | 26-2482738 | |||||||||||||||||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||||||||||||||
110 Washington Street, | Suite 1300 | |||||||||||||||||||||||||
Conshohocken, | PA | 19428 | ||||||||||||||||||||||||
(Address of principal executive offices) | (Zip Code) |
(610) 934-2222
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||||||||
Class A Common Stock, $0.001 par value per share | HLNE | The Nasdaq Stock Market LLC |
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ¨ No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No x
The aggregate market value of Class A common stock held by non-affiliates of the registrant on September 30, 2020, based on the closing price of $64.59 as reported by the Nasdaq Stock Market, was approximately $1,980.4 million.
As of May 26, 2021, there were 36,290,183 shares of the registrant’s Class A common stock and 16,739,846 shares of the registrant’s Class B common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Part III of this Form 10-K incorporates by reference information from the registrant’s definitive proxy statement related to the 2021 annual meeting of stockholders.
EXPLANATORY NOTE
This Amendment No. 1 on Form 10-K/A (this “Amendment”) amends the Annual Report on Form 10-K of Hamilton Lane Incorporated (the “Company”) for the fiscal year ended March 31, 2021, originally filed with the Securities and Exchange Commission (the “SEC”) on May 27, 2021 (the “Original Filing”).
The Company is filing this Amendment to: (i) amend Item 9B of Part II to disclose information regarding compensatory awards to certain of the Company’s named executive officers that was required to be disclosed on a Current Report on Form 8-K during the fourth quarter of the fiscal year covered by this Annual Report on Form 10-K, but which was not timely reported on a Form 8-K during that period; (ii) amend the Exhibit Index referenced in Item 15 of Part IV to add related Exhibits 10.32, 10.33 and 10.34; and (iii) update the Company’s well-known seasoned issuer status as a result of the foregoing. This Amendment also contains currently dated certifications under the Sarbanes-Oxley Act of 2002, filed as exhibits 31.3, 31.4 and 32.
Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, this Amendment contains only the changes noted above. Those sections or exhibits of the Original Filing that are unaffected by this Amendment (including the financial statements included in the Original Filing) are not included herein.
This Amendment continues to speak as of the date of the Original Filing, and the Company has not updated the disclosure contained herein to reflect events that have occurred since the filing of the Original Filing or modified those disclosures that may be affected by subsequent events. Accordingly, this Amendment should be read in conjunction with the Company’s other filings made with the SEC subsequent to the filing of the Original Filing.
PART II
Item 9B. Other Information
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In January 2021, Hamilton Lane Incorporated (the “Company”) closed an initial public offering (“IPO”) for a special purpose acquisition company, Hamilton Lane Alliance Holdings I, Inc. (“HLAH”). HLAH is sponsored by HL Alliance Holdings Sponsor LLC (the “Sponsor”), an indirect wholly-owned subsidiary of the Company. As part of HLAH’s initial public offering, the Sponsor purchased 5,013,333 warrants from HLAH (the “Warrants”). Each Warrant entitles its holder to purchase one share of Class A common stock of HLAH, par value $0.0001 per share (each, a “Share”), at an exercise price of $11.50 per Share, subject to adjustment.
On March 3, 2021, the Compensation Committee of the Company’s Board of Directors approved the transfer by the Sponsor of Warrants to certain employees of the Company as permitted transferees for services rendered in connection with HLAH, including the following named executive officers:
Name | Number of Warrants | Grant Date Fair Value | ||||||||||||
Erik R. Hirsch | 501,333 | $ | 576,533 | |||||||||||
Atul Varma | 75,200 | $ | 86,480 |
Subject to certain conditions, the Warrants become exercisable upon the later of: (i) the date that is 30 days after the date on which HLAH completes a merger or other business combination with a target company (a “Business Combination”); or (ii) the date that is 12 months from the date of the closing of the HLAH IPO, and terminating on the earliest to occur of: (x) the date that is five years after the date on which HLAH completes its initial Business Combination; or (y) the liquidation of HLAH if HLAH fails to complete a Business Combination. If HLAH does not complete a Business Combination within the prescribed period, the Warrants will expire worthless. The Warrants will generally be non-redeemable for cash and exercisable on a cashless basis so long as they are held by permitted transferees. Additionally, the Warrants may only be transferred to permitted transferees until 30 days after the completion of a Business Combination.
The foregoing description of the Warrants does not purport to be complete and is qualified in its entirety by reference to the: (i) Warrant Agreement, dated January 15, 2021, by and between HLAH and Continental Stock Transfer & Trust Company; (ii) Letter Agreement, dated January 15, 2021, among HLAH, the Sponsor and each of HLAH’s officers and directors; and (iii) Form of Warrant Assignment and Transfer, which are each filed as exhibits to this Form 10-K/A and incorporated herein by reference as if fully set forth hereto.
PART IV
Item 15. Exhibit and Financial Statement Schedules
The following documents are filed as part of this Form 10-K:
1. All financial statements. See Index to Consolidated Financial Statements in Item 8 of this Form 10-K.
2. Financial Statement Schedules. Financial statement schedules are omitted as they are either not required or the information is otherwise included in the consolidated financial statements.
3. Exhibits. See Exhibit Index.
Exhibit Index
Incorporated By Reference | Filed Herewith | ||||||||||||||||||||||
Exhibit No. | Description of Exhibit | Form | Exhibit | Filing Date | File No. | ||||||||||||||||||
8-K | 3.1 | 3/10/17 | 001-38021 | ||||||||||||||||||||
10-K | 3.2 | 6/27/17 | 001-38021 | ||||||||||||||||||||
10-K | 4.1 | 5/30/19 | 001-38021 | ||||||||||||||||||||
8-K | 10.1 | 3/10/17 | 001-38021 | ||||||||||||||||||||
S-1 | 10.2 | 2/26/18 | 333-223235 | ||||||||||||||||||||
10-K | 10.3 | 6/14/18 | 001-38021 | ||||||||||||||||||||
8-K | 10.2 | 3/10/17 | 001-38021 | ||||||||||||||||||||
10-Q | 10.1 | 2/2/21 | 001-38021 | ||||||||||||||||||||
8-K | 10.3 | 3/10/17 | 001-38021 | ||||||||||||||||||||
10-Q | 10.3 | 2/9/18 | 001-38021 | ||||||||||||||||||||
8-K | 10.4 | 3/10/17 | 001-38021 |
5
Incorporated By Reference | Filed Herewith | ||||||||||||||||||||||
Exhibit No. | Description of Exhibit | Form | Exhibit | Filing Date | File No. | ||||||||||||||||||
8-K | 10.5 | 3/10/17 | 001-38021 | ||||||||||||||||||||
S-1/A | 10.6 | 2/16/17 | 333-215846 | ||||||||||||||||||||
10-Q | 10.2 | 2/9/18 | 001-38021 | ||||||||||||||||||||
S-1/A | 10.7 | 2/16/17 | 333-215846 | ||||||||||||||||||||
10-Q | 10.1 | 2/9/18 | 001-38021 | ||||||||||||||||||||
S-1/A | 10.8 | 2/16/17 | 333-215846 | ||||||||||||||||||||
10-Q | 10.2 | 8/9/18 | 001-38021 | ||||||||||||||||||||
DEF14A | Appendix A | 7/27/18 | 001-38021 | ||||||||||||||||||||
10-Q | 10.1 | 8/4/20 | 001-38021 | ||||||||||||||||||||
S-1/A | 10.9 | 2/16/17 | 333-215846 | ||||||||||||||||||||
8-K | 10.1 | 8/25/17 | 001-38021 | ||||||||||||||||||||
8-K | 10.2 | 3/25/20 | 001-38021 | ||||||||||||||||||||
10-Q | 10.1 | 11/4/20 | 001-38021 | ||||||||||||||||||||
8-K | 10.1 | 4/27/21 | 001-38021 | ||||||||||||||||||||
8-K | 10.2 | 8/25/17 | 001-38021 |
6
Incorporated By Reference | Filed Herewith | ||||||||||||||||||||||
Exhibit No. | Description of Exhibit | Form | Exhibit | Filing Date | File No. | ||||||||||||||||||
8-K | 10.3 | 3/25/20 | 001-38021 | ||||||||||||||||||||
10-Q | 10.2 | 11/4/20 | 001-38021 | ||||||||||||||||||||
8-K | 10.1 | 3/25/20 | 001-38021 | ||||||||||||||||||||
10-Q | 10.3 | 11/4/20 | 001-38021 | ||||||||||||||||||||
8-K | 10.2 | 4/27/21 | 001-38021 | ||||||||||||||||||||
10-K | 10.12 | 6/27/17 | 001-38021 | ||||||||||||||||||||
8-K | 10.1 | 1/2/20 | 001-38021 | ||||||||||||||||||||
10-K | 10.31 | 5/27/21 | 001-38021 | ||||||||||||||||||||
8-K | 4.1 | 1/19/21 | 001-39884 | ||||||||||||||||||||
8-K | 10.1 | 1/19/21 | 001-39884 | ||||||||||||||||||||
X | |||||||||||||||||||||||
10-K | 21.1 | 5/27/21 | 001-38021 |
7
Incorporated By Reference | Filed Herewith | ||||||||||||||||||||||
Exhibit No. | Description of Exhibit | Form | Exhibit | Filing Date | File No. | ||||||||||||||||||
10-K | 23.1 | 5/27/21 | 001-38021 | ||||||||||||||||||||
10-K | 31.1 | 5/27/21 | 001-38021 | ||||||||||||||||||||
10-K | 31.2 | 5/27/21 | 001-38021 | ||||||||||||||||||||
X | |||||||||||||||||||||||
X | |||||||||||||||||||||||
32‡ | |||||||||||||||||||||||
101 | The following financial information from our Annual Report on Form 10-K for the year ended March 31, 2021 formatted in Inline XBRL (Extensible Business Reporting Language) includes: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Stockholders’ Equity, (v) the Consolidated Statements of Cash Flows and (vi) Notes to the Consolidated Financial Statements. | 10-K | 101 | 5/27/21 | 001-38021 | ||||||||||||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | X |
† Indicates a management contract or compensatory plan or arrangement.
○ Confidential information in this exhibit has been omitted.
‡ Furnished herewith.
8
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 15th day of July, 2021.
HAMILTON LANE INCORPORATED | |||||
By: | /s/ Mario L. Giannini | ||||
Name: Mario L. Giannini | |||||
Title: Chief Executive Officer |